Gambia: Govt to Prosecute Dr. Mbowe On Jammeh's 'False' HIV Treatment

The government of The Gambia through the Whitepaper on the recommendations of the TRRC findings will charge and prosecute former President Yahya Jammeh and Dr Tamsir Mbowe with murder for intentionally and knowingly causing the death of People Living With HIV/AIDS (PLHIV), who were conscripted in the sham PATP and deprived of life-saving treatment.

The President's Alternative Treatment Programme was an alternative medicine treatment programme initiated and advocated by former President Yahya Jammeh, who claimed he could cure HIV/AIDS and other ailments.

The Whitepaper further accepted the prosecution of Yahya Jammeh and Dr Tamsir Mbowe for negligence causing deaths of PLHIV who took part in the programme and were deprived from lifesaving treatment.

The government will also prosecute them for the inhumane and degrading treatment meted out on PLHIV that took part in the treatment programme, and for admitting children into the PATP in violation of the provisions of the Children's Act 2005 and the Convention on the Rights of the Child.

The government will as well revoke Dr Tamsir Mbowe's practising licence indefinitely for failing to honour the medical code of conduct and for the role he played in the fake PATP.

The strengthening of the existing regulations on the use of herbal medical products through the effective enforcement of the Medicines and Related Products Act, 2014 was also accepted.

AllAfrica publishes around 600 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.

X